Biohaven Ltd. (BHVN)
Healthcare
Biotechnology
13.50 $
-2.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Biohaven Ltd. (BHVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -150 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -44 | -95 | -115 | -103 | -168 | -141 | -171 | -165 | -168 | -146 | -131 | -150 | -594 | |
| 1.8 | 1.5 | 0.9 | 0.9 | 1.0 | 2.0 | 2.5 | 2.2 | 2.0 | 3.1 | 2.6 | 2.4 | 10 | |
| 4.7 | 4.5 | 16 | 35 | 12 | 12 | 13 | 53 | 21 | 22 | 17 | 28 | 88 | |
| 3.4 | 3.4 | – | – | – | – | – | – | – | – | – | – | – | |
| 41 | 2.8 | -8.7 | 26 | -23 | 21 | -6.0 | -4.4 | 19 | -3.0 | -9.8 | -53 | -47 | |
| 0.6 | 1.2 | 0.5 | 0.4 | 2.9 | 0.6 | 0.0 | 0.5 | 0.2 | 0.0 | 0.0 | 0.0 | 0.3 | |
| 76 | 59 | -3.9 | 34 | -98 | -93 | -88 | 165 | -16 | 165 | -14 | 15 | 151 | |
| – | – | – | – | – | – | 12 | – | – | – | 1.8 | – | – | |
| – | – | – | – | – | 0.0 | – | – | – | 0.0 | 0.0 | – | – | |
| -20 | -40 | 210 | 3.4 | 321 | 80 | 273 | 0.4 | 250 | 0.1 | 189 | 179 | 618 | |
| 11 | -76 | 126 | -65 | 55 | -154 | 15 | 0.1 | 66 | 19 | 44 | 44 | 174 | |
| -45 | -96 | -115 | -103 | -171 | -142 | -171 | -166 | -168 | -146 | -131 | -150 | -594 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.